Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286
Allan R. Tenorio*, Ellen S. Chan, Ronald J. Bosch, Bernard J.C. Macatangay, Sarah W. Read, Suria Yesmin, Babafemi Taiwo, David M. Margolis, Jeffrey M. Jacobson, Alan L. Landay, Cara C. Wilson
Dive into the research topics of 'Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286'. Together they form a unique fingerprint.